글로벌 측두동맥염 시장 – 2029년까지의 산업 동향 및 예측

측두동맥염 시장 분석 및 규모

글로벌 측두동맥염 시장은 예측 기간 동안 상당한 성장을 보일 것으로 예상됩니다. 측두동맥염의 병인은 지금까지 알려지지 않았지만 신체의 자가면역 체계와 관련이 있을 수 있습니다. 이에 더하여, 더 높은 용량의 항생제와 여러 가지 심각한 감염이 측두동맥염과 관련이 있습니다. 측두동맥염에 대한 예방이나 치료법은 아직 없습니다. 그러나 측두동맥염 진단 후 합병증을 줄임으로써 치료할 수 있습니다.

Data Bridge Market Research는 2022-2029년 예측 기간 동안 글로벌 측두동맥염 시장의 성장률을 분석합니다. 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자, 시장 시나리오와 같은 시장 통찰력 외에도 Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석, 규제 프레임워크도 포함됩니다.

측두동맥염 시장 범위 및 세분화

Market Definition

Temporal arteritis is also known as Horton's arteritis and is considered to be a severe form of vasculitis which means inflammation of the blood vessels. It is a potentially life-threatening inflammatory condition of the arteries. It can cause scalp tenderness and headaches. This condition usually occurs in temporal arteries and may occur in any medium to large artery of the body. As this condition generally occurs in aged population, it is also known as arteritis of the aged. Other names of temporal arteritis includes Horton disease, arteritis cranialis, and granulomatous arteritis.

Global Temporal arteritis Market Dynamics

Drivers

• Increase in Autoimmune Disorders

According to National Institute of Environmental Health Sciences records, more than 80 autoimmune diseases have been identified, namely diabetes (type 1), lupus, multiple sclerosis, rheumatoid arthritis, and celiac disease. Rise in the occurrence of these diseases pushes the global temporal arteritis market. This factor boosts the growth of the market.

• Rising Demand for Oral Drugs

Oral drugs is projected to boost the market growth. The segment is anticipated to accelerate the global market as most of the products are available in capsule and tablet form and it is a very convenient route of administration. Wide number of patients prefer this route and it leads to the faster recovery as well.

Opportunities

• Increasing Demand of Diagnostic Tests

Several diagnostic tests are available for this treatment that are necessary for the quick recovery of the patients. Diagnosis of temporal arteritis is done by physical examination of the head, haemoglobin test to measure haemoglobin level in blood, or to detect oxygen-carrying protein in blood, liver function test to determine proper functioning of liver, haematocrit test to determine bloods with RBC cells. This boosts the growth of the market.

• Increasing Demand for Retail Pharmacies

The rise in the number of temporal arteritis therapeutics being delivered through retail pharmacies and the surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.

 Restraints/Challenges

• Side Effects of Treatment Procedures

There are several side effects that are associated with the treatment procedures of temporal arteries. It includes a greater chance of fractures as steroids can make the bones thinner and cause infections because steroids somewhat pull down the immune system. Thus, this hampers the growth of the market.

• High Cost

The huge expenditure associated with temporal arteritis medications hamper the market growth. This disease involves treatment with corticosteroids, several immunosuppressive agents that demands huge expenditure. This acts as a major hindrance for the market.

This global temporal arteritis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global temporal arteritis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Temporal Arteritis Market Scope

The global temporal arteritis market is segmented on the basis of treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

• Corticosteroids
• Aristocort
• Bubbli-Pred
• Immunosuppressive Agents
• Adalimumab
• Infliximab
• Anticoagulants
• Rivaroxaban
• Dabigatran
• Others

Route of Administration

• Oral
• Parenteral

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Temporal Arteritis Market Regional Analysis/Insights

The global temporal arteritis market is analyzed and market size insights and trends are provided by treatment, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global temporal arteritis market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has been witnessing a positive growth for global temporal arteritis market throughout the forecasted period due to the increase prevalence of cardiovascular complications and advanced healthcare facilities.

Asia-Pacific dominates the market due to the increase’s cases of cardiovascular diseases and rapidly aging population.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 또한 글로벌 브랜드의 존재와 가용성, 그리고 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.   

경쟁 환경 및 글로벌 측두동맥염 시장 점유율 분석

글로벌 측두동맥염 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 프로그램 우세입니다. 제공된 위의 데이터 포인트는 글로벌 측두동맥염 시장과 관련된 회사의 초점에만 관련이 있습니다.

세계 측두동맥염 시장에서 활동하는 주요 기업은 다음과 같습니다.

• 노바티스 AG(스위스)
• 엔도 인터내셔널 주식회사(아일랜드)
• Teva Pharmaceutical Industries Ltd(이스라엘)
• Glenmark Pharmaceuticals Ltd(인도)
• Cipla Inc(인도)
• Dr Reddy's Laboratories Ltd(인도)
• 애벗(미국)
• F. 호프만-라 로슈 유한회사(스위스)
• 파이저 주식회사(미국)
• Zydus 그룹(인도)
• 루팡(인도)
• Amorphex Therapeutics Holdings, Inc (미국)
• Bausch Health Companies Inc. (캐나다)
• Regeneron Pharmaceuticals Inc (미국)
• 아스텔라스파마 주식회사(일본)

SKU-54490